Dr Kunst and the development of a medicine for psoriasis

Dr Kunst's "drive" to help patients with chronic conditions lead to the development of a medicine to help patients with chronic psoriasis. He did this in collaboration with a pharmacist working in Helmond, the Netherlands and by applying knowledge gained and published by W. Schweckendieck.

Dr. Kunst had seen the clinical benefits of dimethylfumarate (DMF), the discovery by Dr W. Schweckendieck. DMF had been brought to the Netherlands by Dr van Dijk, but this version of it had debilitating effects on the patients' digestive system. 

In 1985 together with the pharmacist, Dr Durlinger, Dr Kunst developed a version of a DMF-pill that had a slow release mechanism (in the new terminology now mentioned as extended release), as a result, the irritating substance is slowly be distributed in the whole of the intestinal tract, diminishing it's corrosive effect. This has the advantage that many more patients can withstand the side-effects of DMF.

This version of the medicine was named Psorinovo, and was made and distributed by Mierlo-Hout pharrmacy, currently called Infinity Pharma. It has been in use to treat thousands of patients with an effectivity of around 70%.  More about this medication and its development can be viewed on the website of Psoriasispatiënten Nederland, the official website of  the Psoriasis Patients Support Group in the Netherlands. 

Dr Kunst was recently interviewed by Psoriasis Magazine, the official publication for Psoriasispatiënten Nederland. The resulting article can be downloaded here. [An English version will be added soon]. 

NB Several patients with psoriasis have since been successfully treated with the autovaccine therapy. This fact makes it likely that there is a microbiological causal factor related to this condition.

 

 

 

Print Email

Autovaccine therapy, summary and Literature

On this site you can find video and text testimonies by a number of patients that show that we can achieve very positive, even spectacular, results using autovaccine therapy. This therapy has a broad application for conditions that regular medical practice does not yet have an answer for. Below you will find a complete - but compact - summary. An extended literature list will show that this therapy, which is still new in the Netherlands, is solidly based on scientific knowledge and research. 

Continue Reading

Print Email

Safety of the autovaccine

Twelve tubes of blood are taken from the patient to make one course of autovaccine therapy. Two extra collection tubes are filled and sent as a control sample to a laboratory once the preparation of the autovaccine has been completed as one batch. All the blood samples in the collection tubes are properly labelled as soon as they have been obtained from the patient to avoid the possibility of accidental exchange with another patient. As explained further on this site, the autovaccine is nothing more than the patient’s own blood – sealed in vacuum tubes - that has been kept at body temperature in sterile conditions, and gently rocked, for the duration of several weeks. This sets off a denaturation process of all bio-active molecules in the blood – with the exception of human and bacterial DNA molecules which are essentially indestructible. This process is called incubation.

Continue Reading

Print Email

Copyright © 2018 Art of Medicure (Leendert Kunst M.D.). All Rights Reserved.